减持计划详情 翁康拟在2025年10月16日至2026年1月15日期间，通过大宗交易方式减持不超过521.425万股，即不超过 其持有公司股份总数的25%，不超过公司总股本的1.7024%；以集中竞价方式减持不超过306.2827万 股，即不超过其持有公司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过521.425万 股。若减持计划期间公司有送股、资本公积金转增股本等股份变动事项，拟减持股份数量将相应调整。 吴镝拟在同一时间段内，通过大宗交易、集中竞价交易减持不超过1.425万股，即不超过其持有公司股 份总数的25%，不超过公司总股本的0.0047%。若减持计划期间公司有送股、资本公积金转增股本等股 份变动事项，拟减持股份数量也将相应调整。 登录新浪财经APP 搜索【信披】查看更多考评等级 9月17日，苏州麦迪斯顿医疗科技股份有限公司（以下简称"麦迪科技"）发布股东减持股份计划公告， 股东翁康、吴镝因个人资金安排，拟在公告十五个交易日后的三个月内减持公司股份。 减持主体情况 截至本次减持计划实施前，翁康持有麦迪科技2085.7003万股，占公司股本总数的6.8097%，股份来源于 IPO前取得。 ...

Group 1: Event Overview - The eighth China International Import Expo (CIIE) is set to open in 50 days, showcasing the vitality of the Chinese market for foreign enterprises [1] - Several long-term exhibitors, referred to as "old friends" of the expo, are preparing to present new innovations and products [1] Group 2: Company Highlights - Schott, a high-tech international group, is integrating natural quartz glass into its special materials matrix, which is crucial for microchip manufacturing [1] - Schott will publicly showcase this technology for the first time in China at the expo, along with other innovative technologies such as glass-metal sealing technology [1] - Medtronic, a long-standing partner of the expo, will present over 100 innovative medical technology products, including the Asia-Pacific debut of its first closed-loop rechargeable spinal cord stimulation system [2] - Medtronic's strategy has evolved from being an exhibitor to an investor, aiming to localize global wisdom and globalize Chinese innovation [2] - Sanofi, also a consistent participant, will focus on groundbreaking innovations in the global immunology field, showcasing breakthrough drugs and vaccines [3] Group 3: Strategic Importance - The CIIE serves as a vital bridge connecting global innovation with the Chinese market, facilitating the transformation of innovations from "imported" to "exported" [2] - Sanofi emphasizes its commitment to the Chinese market as a key engine in its global strategy, aiming to support the development of China's pharmaceutical ecosystem [3]

Core Insights - The 2025 Service Trade Fair in Beijing showcased innovative healthcare solutions, including AI-assisted self-diagnosis rooms and wearable devices for real-time health monitoring, highlighting the integration of technology in healthcare [2] Group 1: AI and Traditional Medicine Integration - The China Academy of Chinese Medical Sciences demonstrated a small-scale meridian conditioning robot for treating tension-type headaches, emphasizing the stability and effectiveness of machine-assisted treatments over manual methods [3] - The "AI consultation" platform, powered by a large model, offers a comprehensive self-service experience from triage to follow-up, showcasing the potential of AI in traditional Chinese medicine [3][5] Group 2: Surgical Robotics and AI Applications - Advanced surgical robots, including a microwave water knife and AI catheter shaping robots, were introduced, addressing common challenges in minimally invasive surgeries and enhancing precision in tumor removal [6] - An AI visual monitoring system for critical care was presented, capable of real-time patient monitoring and early warning for adverse events, demonstrating the growing role of AI in patient safety and decision-making [6][8] Group 3: Pediatric Health Innovations - The fair highlighted intelligent solutions for children's health, such as a smart fundus camera that aids in eye health screenings for young children, improving access to quality care [9] - A companion robot designed for children with high-functioning autism provides interactive assessments and training, supporting early diagnosis and rehabilitation efforts [11]

Group 1 - A pen equipped with sensors can assist in the early screening and medication guidance for Parkinson's disease, with plans for market launch next year [3][5] - An AI retinal camera generates risk assessment reports for conditions such as hypertension, diabetes, and stroke from a single eye photo, attracting significant interest from elderly attendees [7] - A capsule-sized endoscope for digestive system examinations captures thousands of images and presents them in a panoramic view, with capabilities for remote transmission [9] Group 2 - AI-driven products related to traditional Chinese medicine are showcased, including a digital guide named "An An" that recommends departments based on multi-round consultations and seasonal health advice [11] - The integration of artificial intelligence and big data is transforming healthcare service models, with expectations for improved service quality as these innovations are adopted [13]

Group 1 - The 2025 Service Trade Fair has entered its fourth day, featuring a public open day and showcasing the latest technologies and services in the healthcare sector under the theme "Smart Leading Future Health Life" [1] - The health and hygiene services area has become one of the most popular exhibition zones at this year's fair, highlighting advanced medical equipment such as microwave water knife laparoscopic surgical robots and single-port laparoscopic surgical robots [1] - A notable innovation is the panoramic reconstruction capsule robot, which navigates the digestive tract autonomously and can identify millimeter-level lesions using AI, potentially reducing the need for traditional gastrointestinal examinations [1] Group 2 - In the field of orthopedics, robotic assistance is now available for surgeries involving the spine and joints, enhancing precision and minimizing damage to surrounding tissues during procedures like ligament reconstruction [2] - The Beijing Red Cross Blood Center introduced a fully automated blood labeling and packaging robot system, which integrates machine vision recognition and robotic loading, generating over 8 million data entries annually for scientific decision-making [2]

Core Viewpoint - The announcement details the pledge of shares by the controlling shareholder of Saily Medical Technology Group Co., Ltd., indicating a significant portion of shares has been pledged, but the company maintains that this will not affect its operations or control [2][5][6]. Group 1: Share Pledge Details - The controlling shareholder, Saihai (Shanghai) Health Technology Co., Ltd., holds 21,642,540 shares, representing 10.30% of the total share capital, and has pledged 3,000,000 shares recently [2]. - After the recent pledge, Saihai Technology has a total of 17,000,000 pledged shares, which is 78.55% of its holdings and 8.09% of the total share capital [2]. - The actual controller, Mr. Wen Wei, holds 9,634,208 shares (4.58% of total share capital) and has pledged 5,300,000 shares, which is 55.01% of his holdings [2]. Group 2: Future Pledge and Financing - Within the next six months, 6,000,000 shares are set to mature, accounting for 19.18% of their holdings and 2.86% of total share capital, with a corresponding financing balance of 14.61 million yuan [5]. - In the next year, an additional 9,000,000 shares will mature, representing 28.78% of their holdings and 4.28% of total share capital, with a financing balance of 36 million yuan [5]. - The funds from the recent pledge are primarily intended to repay previous pledge financing debts, and the company asserts that it has the ability to repay these debts [5][6]. Group 3: Risk Management and Impact - The company states that the pledge will not impact its operations, main business, financing costs, or ongoing viability, and there is no risk of a change in actual control [6]. - The credit status of Saihai Technology and Mr. Wen Wei is reported to be good, with manageable pledge risks, and they are prepared to take measures if stock prices approach warning or liquidation levels [6].

据长木谷展台工作人员李佳音介绍，传统骨科手术室术中操作高度依赖外科医生的个人经验与肉眼判 断，其精准度和可预测性难以得到根本保障，而该产品填补了人工智能与机器人技术在骨科手术全流程 覆盖中的应用空白，配备AI全骨科智能规划系统，将传统手术规划时间从数周压缩至分钟级，仅需CT 影像，即可在5分钟生成个性化三维手术方案。 李佳音提到，术中，机器人的数智脑、数智眼、数智手可以三位一体地模拟非常有年资的骨科专家的经 验，来进行手术的精准执行，通过5G远程技术提供实时手术直播、跨国会诊和远程指导服务，实现无 地域、无限定场景的应用边界突破。 9月10日—14日，2025年中国国际服务贸易交易会（以下简称"服贸会"）在北京首钢园举行。位于首钢 园2号馆的健康卫生服务专题展以"智领未来，健康生活"为年度主题，记者在馆内看到，长木谷展台吸 引许多观众驻足，据了解，长木谷在本次服贸会期间首次出展了AI+手术机器人5G远程诊疗一体化平台 数智骨科手术室。 （文章来源：21世纪经济报道） ...

Core Insights - The article highlights the advancements in future healthcare technologies showcased at the service trade fair, including acupuncture therapy robots, AI doctors, and surgical robots [1]. Group 1 - The service trade fair features innovative healthcare solutions that are becoming increasingly accessible [1]. - Various technologies such as acupuncture therapy robots and AI-driven medical assistance are presented as key attractions [1]. - The article prompts readers to express interest in specific technologies, indicating a focus on consumer engagement and awareness [1].

Core Insights - Medpark held its first investment and financing meeting of the month on September 12, inviting banking institutions to facilitate diversified financing channels for enterprises within the park [1] - Six companies from Medpark, including Bozhi Medical, Ouchang Medical, Tianhai Jiahe, Keman Medical, Guoke Kangcheng, and Aipubai Biotechnology, presented their core technologies, business models, and market prospects, covering sectors such as intelligent assisted reproduction, surgical robots, biomaterials, intelligent medical imaging, and in vitro diagnostics [1] Group 1 - The event maintained the traditional investment matching model while enhancing it by including banks to improve financing options for companies [1] - Active discussions took place at the meeting, with enterprises engaging with representatives from banks and investment institutions on issues such as technology transfer, market expansion, and financing needs [8] - Participating companies reported that the combined "equity + debt" financing approach effectively meets both short-term operational and long-term developmental funding requirements, thereby increasing financing efficiency [8] Group 2 - Medpark plans to continue regular investment and financing matching activities, optimizing financing service models to provide comprehensive financial support for the innovative development of enterprises within the park [8]

Core Insights - The "Artificial Intelligence + Healthcare" seminar successfully took place during the 2025 China International Service Trade Fair, focusing on the integration of AI and healthcare, and announced significant achievements from the National AI Application Pilot Base in Beijing [1] Group 1: AI Applications in Healthcare - Over a hundred AI applications have been developed, covering 30 critical clinical scenarios, enhancing precision diagnosis and accelerating biopharmaceutical manufacturing [2] - The pilot base released four key achievements in precision diagnosis, including a secure medical data space service, a comprehensive medical data annotation service, and a unified AI application promotion service [2][3] Group 2: Collaboration and Partnerships - The seminar facilitated efficient connections between hospitals, research institutions, and pharmaceutical companies, resulting in several cooperation agreements [3] - The pilot base collaborated with three major hospitals to release significant results, including an ultrasound diagnostic model for cardiovascular diseases and an AI system for liver and gallbladder diagnostics [4] Group 3: Advancements in Biopharmaceutical Manufacturing - The pilot base introduced two major achievements aimed at improving pharmaceutical manufacturing efficiency, including a public service platform for drug development and a clinical trial management system [3]